申请人:——
公开号:US20020151715A1
公开(公告)日:2002-10-17
Novel imidazole derivatives are disclosed. These compounds have a good affinity to the NMDA (N-methyl-D-aspartate)-receptor subtype selective blockers, which have a key function in modulating neuronal activity and plasticity which makes them key players in mediating processes underlying development of CNS as well as learning and memory formation. These compounds are useful in the control or treatment of diseases mediated by this receptor.
揭示了新型咪唑衍生物。这些化合物对NMDA(N-甲基-D-天冬氨酸)受体亚型选择性阻滞剂具有良好的亲和力,这些受体在调节神经元活动和可塑性中起着关键作用,使它们成为介导中枢神经系统发育以及学习和记忆形成过程的关键因素。这些化合物在控制或治疗由这种受体介导的疾病中很有用。